Patents by Inventor Guanglin WENG

Guanglin WENG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250145627
    Abstract: The present invention relates to a compound represented by general formula (I) or a stereoisomer, a tautomer, a deuterated substance, a solvate, a prodrug, a metabolite and a pharmaceutically acceptable salt or eutectic crystal thereof, an intermediate thereof, and a use of the compound in METTL3-related diseases such as cancer.
    Type: Application
    Filed: February 14, 2023
    Publication date: May 8, 2025
    Inventors: Chen Zhang, Ming Lei, Tao Mou, Yan Yu, Pingming Tang, Yifei Meng, Guanglin Weng, Yao Li, Pangke Yan
  • Publication number: 20240124470
    Abstract: A compound represented by general formula (I) or a stereoisomer, tautomer, deuterated substance, solvate, prodrug, metabolite, pharmaceutically acceptable salt or co-crystal thereof, an intermediate thereof and a preparation method therefor, as well as an application in preparation of a drug for treating diabetes.
    Type: Application
    Filed: December 24, 2021
    Publication date: April 18, 2024
    Inventors: Chen ZHANG, Ming LEI, Mingliang ZHAO, Yan YU, Pingming TANG, Guanglin WENG, Tao MOU, Yao LI, Jia NI, Pangke YAN